| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 239.193 | 216.967 | 210.014 | 192.194 | 227.661 | 237.728 | 244.790 | 326.463 | 410.924 | 445.967 |
| Total Income - EUR | 239.196 | 217.020 | 210.122 | 192.297 | 229.775 | 238.338 | 247.090 | 330.661 | 412.717 | 446.700 |
| Total Expenses - EUR | 212.173 | 207.996 | 194.270 | 182.299 | 215.839 | 215.639 | 223.987 | 296.135 | 370.392 | 417.517 |
| Gross Profit/Loss - EUR | 27.023 | 9.024 | 15.852 | 9.997 | 13.936 | 22.699 | 23.103 | 34.526 | 42.325 | 29.183 |
| Net Profit/Loss - EUR | 22.411 | 5.286 | 13.338 | 8.059 | 11.623 | 20.935 | 20.682 | 31.220 | 38.395 | 25.048 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 4 |
Check the financial reports for the company - Farmasan Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.935 | 3.223 | 15.679 | 11.552 | 7.562 | 3.746 | 2.709 | 5.068 | 19.170 | 17.526 |
| Current Assets | 100.870 | 71.662 | 61.432 | 65.535 | 67.386 | 71.940 | 79.903 | 113.075 | 119.133 | 130.700 |
| Inventories | 25.542 | 25.732 | 26.117 | 17.080 | 19.303 | 15.713 | 21.500 | 33.137 | 50.166 | 79.074 |
| Receivables | 40.984 | 14.581 | 30.809 | 36.882 | 32.597 | 38.643 | 40.481 | 76.542 | 62.849 | 49.012 |
| Cash | 34.344 | 31.349 | 4.506 | 11.573 | 15.487 | 17.584 | 17.922 | 3.396 | 6.118 | 2.614 |
| Shareholders Funds | 31.417 | 14.201 | 22.102 | 29.755 | 20.059 | 20.985 | 20.730 | 31.268 | 38.443 | 41.425 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 72.387 | 60.685 | 55.009 | 47.331 | 54.889 | 54.701 | 61.882 | 86.875 | 99.860 | 106.801 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Farmasan Srl